Two different risk calculators to assess pre-biopsy PCa risk have been recently developed and made available online: the PCPT-derived Cancer Risk Calculator for Prostate Cancer (PCPT-CRCPC) and the ERSPC-derived SWOP Prostate-Risk Indicator (SWOP-PRI). We evaluate their performance in a clinical...
The first version of the Prostate Cancer Risk Calculator, developed in 2006 to help men and their doctors assess their risk for prostate cancer, has been completely revamped. Version 2.0 uses current risk factors and gives a more nuanced result to help a man and his physician understand the ...
Diagnostic Biomarkers:These biomarkers help diagnose specific diseases or conditions. For example, elevated levels of prostate-specific antigen (PSA) in blood tests can indicate prostate cancer. Prognostic Biomarkers:These biomarkers predict the likely outcome or course of a disease. They help clinicians...
The significant global burden of endometrial cancer (EC) and the challenges associated with predicting EC recurrence indicate the need for a dynamic prediction model. This study aimed to propose nomograms based on clinicopathological variables to predict recurrence-free survival (RFS) and overall surviva...
Methods: An ongoing, prospective, multi-centre clinical registry of patients who underwent focal LDR brachytherapy for low-intermediate risk prostate cancer from September 2019 (LIBERATE Clinical Registry, Icon Cancer Centre) was utilised to evaluate toxicities up to at least 12 months following implant...
Shariat SF, Karakiewicz PI, Suardi N, Kattan MW (2008a) Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 14: 4400–4407. Article CAS PubMed Google Scholar Shariat SF, Walz J, Roehrborn CG, Z...
For this reason we have created here a ‘master guide’ for common health concerns that defines what the condition is, what the symptoms are, any preventative strategies, what the risk factors are that may lead to the problem in the first place, and what clinical treatment and medication opti...
Shariat SF, Karakiewicz PI, Suardi N, Kattan MW (2008a) Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 14: 4400–4407. Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, ...
Shariat SF, Karakiewicz PI, Suardi N, Kattan MW (2008a) Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 14: 4400–4407. Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P...
Suitability of prostate cancer education materials: applying a standardized assessment tool to currently available materials. Patient Educat Couns. 2004;55:275–80. Article Google Scholar SPSS Software. IBM. 2019. https://www.ibm.com/analytics/spss-statistics-software. Accessed 24 Mar 2020. Kitchel...